Back to Agenda
Session 2 of Highlighted Presentations Followed by Q&A
Speaker(s)
Revision of ICH E2D – Scope and Status Update
Vicki Edwards, RPh
Abbvie, United Kingdom
Vice President, Pharmacovigilance Excellence and International QPPV
The New Clinical Trial Legislation - Impact on EudraVigilance
Nick Halsey
European Medicines Agency, Netherlands
Scientific Administrator
Have an account?